![Parand Darou Pharma](https://www.pharmacompass.com/image/flap/parand-darou-desktop-headergif-12950.gif)
![Parand Darou Pharma](https://www.pharmacompass.com/image/flap/parand-darou-mobgif-20656.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/18/2900341/16259/en/Assembly-Biosciences-Doses-First-Participant-in-Phase-1b-Clinical-Trial-Evaluating-Next-Generation-Capsid-Assembly-Modulator-Candidate-ABI-4334-for-the-Treatment-of-Chronic-Hepatit.html
https://www.globenewswire.com/news-release/2024/06/17/2899596/16259/en/Assembly-Biosciences-Announces-12-6-Million-in-Equity-Financings.html
https://www.globenewswire.com/news-release/2024/06/10/2895929/16259/en/Assembly-Biosciences-Doses-First-Participant-in-Phase-1a-b-Clinical-Trial-of-Herpes-Simplex-Virus-Helicase-Primase-Inhibitor-Candidate-ABI-5366.html
https://www.globenewswire.com/news-release/2024/06/05/2893808/16259/en/Assembly-Biosciences-Presents-New-Data-Highlighting-Hepatitis-D-Virus-Entry-Inhibitor-ABI-6250-at-the-EASL-Congress-2024.html
https://www.globenewswire.com/news-release/2024/05/22/2886423/16259/en/Assembly-Biosciences-to-Present-Data-at-Upcoming-International-Herpesvirus-Workshop-and-EASL-Congress-2024.html
https://www.globenewswire.com/news-release/2024/05/08/2878181/16259/en/Assembly-Biosciences-Reports-First-Quarter-2024-Financial-Results-and-Recent-Highlights.html
https://www.globenewswire.com/news-release/2024/03/28/2854455/16259/en/Assembly-Biosciences-Reports-Fourth-Quarter-and-Year-End-2023-Financial-Results-and-Recent-Highlights.html
https://www.globenewswire.com//news-release/2024/02/08/2825969/16259/en/Assembly-Biosciences-Announces-Effective-Date-of-Reverse-Stock-Split.html
https://www.globenewswire.com//news-release/2024/01/04/2803936/16259/en/Assembly-Biosciences-Provides-Anticipated-Development-Milestones-for-2024.html
https://www.globenewswire.com//news-release/2023/11/10/2778507/16259/en/Assembly-Biosciences-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html